Skip to main content

Nanobots are not the future of medicine.

This article covers the recent advance in using nanotechnology as a delivery vector for treatment of cancer pathologies. I have seen many of articles like this on promising ways being probed to use nanotechnology or nanomaterials in order to treat cancer but I see it as a research dead end. The reason has everything to do with where we are in the process of discovering precisely how tissues are expressed from the underlying genes in our DNA.

As a therapy to kill tumors that have formed it apparently works (as shown in this article) but that doesn't fix the underlying pathology that led to the emergence of the cancer (which in many cases can be purely genetic with a low environmental component) To cure cancer one would need to effect repair to these genetic causation factors. It makes no sense at all given what is *rapidly* being discovered about the pathological details that cause cancer as well as other diseases to stop at *treating* cancer when we will very shortly be able to cure it with methods just as non invasive. (in fact likely using denuded viral vectors instead of nanotech ones to deliver the genetic cure as done here as well as kill targeted cancer cells). There is also the potential danger of the constituents of artificially constructed nano-machines are they really broken up completely and flushed out harmlessly or can they serve as the seed for developing new pathology? A viral vector delivered gene therapy would not be subject to this fear as the default payload is removed.

Using nanobots to try and cure cancer is like choosing to hammer a nail by using a pair of vice grips clamped to the end of a hammer. It makes no sense at all given what is *rapidly* being discovered about the pathological details that cause cancer as well as other diseases. I give it 10 years tops to be cured using some form of genetic therapy and I am not restricting this prediction to just the easy cancers; brain cancer, pancreatic cancer, late stage melanoma and lung cancers...all of them are on the same chopping block. Just last year a team of researchers was able to sequence in detail the genetic changes that led to the emergence of lung and skin cancers, they could even tell when the genetic damage occurred and when the cancerous change was induced. I'll try and find the link but it easily stands as the most exciting paper from 2009.

The stem cell research of the last 6 years has opened up an amazing ability to parallel process the discovery phase of all the genes and proteins associated with cell development for particular types of tissue but more importantly allows the gene expression sequence to be spied as the cells go through their stages. The work now is simply performing the necessary reading of the expression patterns (and generated enzymes and proteins) and compare normal to pathological patterns to determine in which genes things go wrong most often and to devise ways to inject repairs using gene therapy in situ. 10 years ago when the human genome was sequenced the worry was that the next step of deciphering the proteome would be next to impossible (given the massive number of possible proteins that can be expressed with our tiny set of 25,000 genes) what was missing was knowledge of how genes might be compartmentalized such that their triggered activity is correlated with particular cellular processes.

Ironically (a huge irony) the investigations of stem cells to determine just what can be learned about their function was spurred in the US by the Bush administration cutting funding for embryonic stem cell development. So what did researchers do? They started playing with other types of stem cells and a few years ago were able to turn normal differentiated cells INTO stem cells in the process known as iPSC (for which the Japanese researcher who pioneered the work will SURELY win a Nobel in a few years time) so this is allowing the expression catalog of the entire human genome to be built by watching stem cells induced to be the required tissue and then "listening" (as in music) for the notes that play out the expressed genes to produce the particular behavior of that cell type. Imagine a floor full of baseball cards and then being tasked with categorizing them by team. One would start out by picking up the cards and looking at the colors on their faces, the player on the surface or even better the team. If they focus on colors they could get the cards cataloged over time but it would take far longer if they focused on team as the teams are relatively invariant over time compared to card color...also the set of teams is reasonably manageable compared to cataloging by publish year or player. The use of stem cells is performing the smart categorization for us of the genes, each tissue type is an analog to a team in which are expressed (from year to year) a particular set of players in positions to execute the game (in hopes of winning and becoming world series winners hopefully) ...If we know the genes that are expressed in the stem cells, it is a short leap to find the differences that make them unique from the differentiated cells of the same stem line which has associated genes which may or may not be consistent between lines (my guess they are) the point is the previously believed to be impossible task of processing through a huge set of possible protein combination blindly was illusory, the system is a record (through it's use of stem cells for each cell type) of the categorization process that is employed to produce all of us...and the smaller set of genes are easier targets to explore when studying pathologies like cancer or other diseases. We are on the verge of a sudden fall off in the lethal capability of tissue born disease like none ever seen before, my only worry is what society will do once these revolutions occur. The death rate due to pathological causes will plummet significantly over the next 10 - 15 years and thus people will live longer and reproduce more vigorously..the Earth is already strained from our misuses of her resources...will we be able to refine ourselves as a species to the point where we drop the selfish ways of the present and past in time to enjoy it?

Comments

Popular posts from this blog

the attributes of web 3.0...

As the US economy continues to suffer the doldrums of stagnant investment in many industries, belt tightening budgets in many of the largest cities and continuous rounds of lay offs at some of the oldest of corporations, it is little comfort to those suffering through economic problems that what is happening now, has happened before. True, the severity of the downturn might have been different but the common factors of people and businesses being forced to do more with less is the theme of the times. Like environmental shocks to an ecosystem, stresses to the economic system lead to people hunkering down to last the storm, but it is instructive to realize that during the storm, all that idle time in the shelter affords people the ability to solve previous or existing problems. Likewise, economic downturns enable enterprising individuals and corporations the ability to make bold decisions with regard to marketing , sales or product focus that can lead to incredible gains as the economic

How many cofactors for inducing expression of every cell type?

Another revolution in iPSC technology announced: "Also known as iPS cells, these cells can become virtually any cell type in the human body -- just like embryonic stem cells. Then last year, Gladstone Senior Investigator Sheng Ding, PhD, announced that he had used a combination of small molecules and genetic factors to transform skin cells directly into neural stem cells. Today, Dr. Huang takes a new tack by using one genetic factor -- Sox2 -- to directly reprogram one cell type into another without reverting to the pluripotent state." -- So the method invented by Yamanaka is now refined to rely only 1 cofactor and b) directly generate the target cell type from the source cell type (skin to neuron) without the stem like intermediate stage.  It also mentions that oncogenic triggering was eliminated in their testing. Now comparative methods can be used to discover other types...the question is..is Sox2 critical for all types? It may be that skin to neuron relies on Sox2

AgilEntity Architecture: Action Oriented Workflow

Permissions, fine grained versus management headache The usual method for determining which users can perform a given function on a given object in a managed system, employs providing those Users with specific access rights via the use of permissions. Often these permissions are also able to be granted to collections called Groups, to which Users are added. The combination of Permissions and Groups provides the ability to provide as atomic a dissemination of rights across the User space as possible. However, this granularity comes at the price of reduced efficiency for managing the created permissions and more importantly the Groups that collect Users designated to perform sets of actions. Essentially the Groups serve as access control lists in many systems, which for the variable and often changing environment of business applications means a need to constantly update the ACL’s (groups) in order to add or remove individuals based on their ability to perform cert